Ranitidine therapy for recalcitrant warts in adults: A preliminary study [8]

Journal of the European Academy of Dermatology and Venereology

Volumn 15, Issue 5, 2001, Pages 495-496

  Karaman, G ^a   Sendur N ^a   Sevk E ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; IMMUNOMODULATING AGENT; PLACEBO; RANITIDINE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; IMMUNITY; LETTER; MALE; METHODOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; VERRUCA VULGARIS;

EID: 0034760029     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2001.03408.x     Document Type: Letter

References (8)

1. Cimetidine therapy for recalcitrant warts in adults
2. Cimetidine therapy for multiple viral warts in children
3. Cimetidine therapy for warts: A placebo-controlled, double-blind study
4. Prevention of suppressed cell-mediated immunity in burned mice with histamine-2 receptor antagonist drugs
5. Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity
6. Histamine type-2 receptor antagonist immune modulation II. Cimetidine and ranitidine increase interleukin-2 production
7. Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel